(NASDAQ: CV) Capsovision's forecast annual revenue growth rate of 36.05% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 5.7%, and it is also forecast to beat the US market's average forecast revenue growth rate of 12.56%.
Capsovision's revenue in 2026 is $13,921,000.On average, 5 Wall Street analysts forecast CV's revenue for 2026 to be $821,247,285, with the lowest CV revenue forecast at $779,914,192, and the highest CV revenue forecast at $838,724,054. On average, 5 Wall Street analysts forecast CV's revenue for 2027 to be $1,094,549,633, with the lowest CV revenue forecast at $1,037,348,063, and the highest CV revenue forecast at $1,120,175,079.
In 2028, CV is forecast to generate $2,263,938,433 in revenue, with the lowest revenue forecast at $2,154,038,509 and the highest revenue forecast at $2,307,898,403.